gwen juergens and at the front. good for her for two reasons. knows she is the best runner of the bunch. she knows he likes to say out of trouble. we have seen this in the transition of the zones in the -- transition zones of the past. don't be surprised to see gwen off at about 15 places, she never has a very fast transition. the key holland is a woman to look out for today. stanford could also be a big factor. holland did too much work on the bike. host: a large group of around 26 athletes were first in the second transition. was favorite for the five kilometer run. there is vicky holland, and i can see her being a silver medalist today, personally. that is a bit of a bummer to say that she is not going to win this thing. trevor: we have seen gwen. we have seen gwen so many times just pick off those in front of her. >> stanford is in a great position, holidays and a great position, sarah true, look at this, this is just spectacular. these guys come out every year. it is just remarkable. trevor: the two brits and the two americans? >> yes. trev

we will be talking to robert juergens about the company's big deal. ♪ erik: you are watching "market i am erik schatzker today with net -- with matt miller. celgene has agreed to buy 47.2 oh yeah and dollars. -- by receptors for 7.2 billion dollars. the ceo and chairman bob hugin is here with us. your company has been known for partnership investments. for example, why make an acquisition? quite apart from that path? rob -- >> this is an opportunity to leverage long-term growth. it is the key reported of -- the key component of the recep dose -- of the recepto's proposition. erik: this drug is in phase three trials. matt: big number. erik: you must be incredibly confident about it the potential to exit phase three and become a commercially 50 product. bob: we feel great about it. we believe that we should do all three. and you cannot do any of them if you do not have great internal research. standing internal research is fundamental to have a good partner acquisition strategies. we think having the best access to all the best opportunities in the world is the right strategy but it st